We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-6.88%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.39B
AUM Growth
-$1.88B
Cap. Flow
-$1.67B
Cap. Flow %
-49.21%
Top 10 Hldgs %
42.09%
Holding
110
New
24
Increased
17
Reduced
27
Closed
38

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$163M
2
NXPI icon
NXP Semiconductors
NXPI
+$72.5M
3
PTCT icon
PTC Therapeutics
PTCT
+$72M
4
CI icon
Cigna
CI
+$64.7M
5
SAGE
Sage Therapeutics
SAGE
+$62.5M

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$217M
2
HUM icon
Humana
HUM
+$149M
3
ICUI icon
ICU Medical
ICUI
+$97.4M
4
BABA icon
Alibaba
BABA
+$84.2M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$83.1M

Sector Composition

Rank Sector Weight
1 Healthcare 59.59%
2 Technology 15.32%
3 Financials 1.11%
4 Communication Services 1.02%
5 Consumer Discretionary 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XNTK icon
101
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.06B
– –
-378,000
Closed -$33.2M
XYZ
102
Block Inc
XYZ
$48.4B
– –
-487,346
Closed -$35.3M
WMGI
103
DELISTED
Wright Medical Group Inc
WMGI
– –
-1,183,313
Closed -$35.3M
NTGN
104
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
– –
-121,848
Closed -$578K
ONCE
105
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-154,599
Closed -$15.8M
SNNA
106
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
– –
-2,583,712
Closed -$2.25M
1 2 3 4
5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return

PFM Health Sciences's Q3 2019 Portfolio in Review

As of Q3 2019, PFM Health Sciences held 110 positions worth $3.39B, down 36% from $5.26B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

PFM Health Sciences withdrew a net $1.67B in Q3 2019, closing 38 positions and reducing 27 holdings. Its most notable exit was Humana, an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 55% a quarter earlier, followed by Technology and Financials.

Against the trend, PFM Health Sciences opened a new position in Alexion Pharmaceuticals worth $142M.

  • PFM Health Sciences's largest Q3 2019 buy was Alexion Pharmaceuticals: 1,446,612 shares worth $142M.
  • PFM Health Sciences added most to uniQure in Q3 2019, an estimated $56.8M increase.
  • PFM Health Sciences's biggest Q3 2019 reduction was Allergan plc, cutting an estimated $217M.
  • PFM Health Sciences fully exited Humana in Q3 2019, selling an estimated $149M.
  • PFM Health Sciences's ten largest holdings make up 42% of its $3.39B portfolio in Q3 2019.
  • PFM Health Sciences opened 24 new positions and closed 38 in Q3 2019.
  • PFM Health Sciences's portfolio value fell 36% quarter-over-quarter to $3.39B.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.